Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July–November 2021

Overview of attention for article published in BMC Medicine, September 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 7 X users

Readers on

mendeley: 54 Mendeley

Summary X

So far, Altmetric has seen 10 X posts from 7 X users, with an upper bound of 38,480 followers.

@msabouri Norway is 15% immigrant, and Sweden 19%. And look at the demographics! Hardly the riskiest group. But again, you're focusing on your causes, and ignoring others. Does this look bad? https://t.co/nTuDPVHr6j https://t.co/oUdz3PUFaU

21 Mar 2023

Reply Repost Favourite

@VaxIllusion @milanoIX @DrAseemMalhotra you claimed Norway had studies showing negative efficacy? 😂 https://t.co/ju1Ew84yb3

16 Feb 2023

Reply Repost Favourite

@Darkweb_troll @SwaledaleMutton @PeterSweden7 https://t.co/wLXMvvanPf

12 Jan 2023

Reply Repost Favourite

@thatdidnthurt13 @Rickdicksauce @WhiteHouse How's BMC medicine? https://t.co/ezKrZqS22a

29 Dec 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.